Literature DB >> 18250264

Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography.

Jürgen K Willmann1, Kai Chen, Hui Wang, Ramasamy Paulmurugan, Mark Rollins, Weibo Cai, David S Wang, Ian Y Chen, Olivier Gheysens, Martin Rodriguez-Porcel, Xiaoyuan Chen, Sanjiv S Gambhir.   

Abstract

BACKGROUND: Vascular endothelial growth factor-121 (VEGF121), an angiogenic protein secreted in response to hypoxic stress, binds to VEGF receptors (VEGFRs) overexpressed on vessels of ischemic tissue. The purpose of this study was to evaluate 64Cu-VEGF121 positron emission tomography for noninvasive spatial, temporal, and quantitative monitoring of VEGFR2 expression in a murine model of hindlimb ischemia with and without treadmill exercise training. METHODS AND
RESULTS: 64Cu-labeled VEGF121 and a VEGF mutant were tested for VEGFR2 binding specificity in cell culture. Mice (n=58) underwent unilateral ligation of the femoral artery, and postoperative tissue ischemia was assessed with laser Doppler imaging. Longitudinal VEGFR2 expression in exercised and nonexercised mice was quantified with 64Cu-VEGF121 positron emission tomography at postoperative day 8, 15, 22, and 29 and correlated with postmortem gamma-counting. Hindlimbs were excised for immunohistochemistry, Western blotting, and microvessel density measurements. Compared with the VEGF mutant, VEGF121 showed specific binding to VEGFR2. Perfusion in ischemic hindlimbs fell to 9% of contralateral hindlimb on postoperative day 1 and recovered to 82% on day 29. 64Cu-VEGF121 uptake in ischemic hindlimbs increased significantly (P < 0.001) from a control level of 0.61+/-0.17% ID/g (percentage of injected dose per gram) to 1.62+/-0.35% ID/g at postoperative day 8, gradually decreased over the following 3 weeks (0.59+/-0.14% ID/g at day 29), and correlated with gamma-counting (R2 = 0.99). Compared with nonexercised mice, 64Cu-VEGF121 uptake was increased significantly (P < or = 0.0001) in exercised mice (at day 15, 22, and 29) and correlated with VEGFR2 levels as obtained by Western blotting (R2 = 0.76). Ischemic hindlimb tissue stained positively for VEGFR2. In exercised mice, microvessel density was increased significantly (P<0.001) compared with nonexercised mice.
CONCLUSIONS: 64Cu-VEGF121 positron emission tomography allows longitudinal spatial and quantitative monitoring of VEGFR2 expression in murine hindlimb ischemia and indirectly visualizes enhanced angiogenesis stimulated by treadmill exercise training.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250264      PMCID: PMC4157592          DOI: 10.1161/CIRCULATIONAHA.107.733220

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

Review 1.  Exercise training for claudication.

Authors:  Kerry J Stewart; William R Hiatt; Judith G Regensteiner; Alan T Hirsch
Journal:  N Engl J Med       Date:  2002-12-12       Impact factor: 91.245

2.  AMIDE: a free software tool for multimodality medical image analysis.

Authors:  Andreas Markus Loening; Sanjiv Sam Gambhir
Journal:  Mol Imaging       Date:  2003-07       Impact factor: 4.488

3.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.

Authors:  Robert J Lederman; Farrell O Mendelsohn; R David Anderson; Jorge F Saucedo; Alan N Tenaglia; James B Hermiller; William B Hillegass; Krishna Rocha-Singh; Thomas E Moon; M J Whitehouse; Brian H Annex
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

Review 4.  Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies.

Authors:  Douglas W Losordo; Stefanie Dimmeler
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

Review 5.  Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.

Authors:  Douglas W Losordo; Stefanie Dimmeler
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

6.  Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Authors:  Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

7.  Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activity.

Authors:  Malgorzata Milkiewicz; Olga Hudlicka; Julie Verhaeg; Stuart Egginton; Margaret D Brown
Journal:  Clin Sci (Lond)       Date:  2003-10       Impact factor: 6.124

8.  Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.

Authors:  Eugenio Stabile; Mary Susan Burnett; Craig Watkins; Timothy Kinnaird; Alessia Bachis; Andrea la Sala; Jonathan M Miller; Matie Shou; Stephen E Epstein; Shmuel Fuchs
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

9.  Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue.

Authors:  Erxiong Lu; William R Wagner; Ute Schellenberger; Judith A Abraham; Alexander L Klibanov; Steven R Woulfe; Melissa M Csikari; David Fischer; George F Schreiner; Gary H Brandenburger; Flordeliza S Villanueva
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

Review 10.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

View more
  35 in total

1.  Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPET.

Authors:  Iljung Lee; Kwang Yup Yoon; Choong Mo Kang; Xin Lin; Xiaoyuan Chen; Jung Young Kim; Sung-Min Kim; Eun Kyoung Ryu; Yearn Seong Choe
Journal:  Nucl Med Biol       Date:  2012-03-09       Impact factor: 2.408

2.  Non-invasive Monitoring of Angiogenesis in Cardiology.

Authors:  Martin Rodriguez-Porcel
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-02

3.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

4.  ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model.

Authors:  Carolina A Ferreira; Reinier Hernandez; Yunan Yang; Hector F Valdovinos; Jonathan W Engle; Weibo Cai
Journal:  Mol Pharm       Date:  2018-06-25       Impact factor: 4.939

5.  The Potential of PET in the Management of Peripheral Arterial Disease.

Authors:  Sanjay Divakaran; Piotr S Sobieszczyk; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2019-08-14

6.  In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.

Authors:  Choong Mo Kang; Sung-Min Kim; Hyun-Jung Koo; Min Su Yim; Kyung-Han Lee; Eun Kyoung Ryu; Yearn Seong Choe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-25       Impact factor: 9.236

Review 7.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

8.  Advances in radionuclide molecular imaging in myocardial biology.

Authors:  Alan R Morrison; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

9.  Quantitative PET imaging of VEGF receptor expression.

Authors:  Kai Chen; Weibo Cai; Zi-Bo Li; Hui Wang; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2008-09-11       Impact factor: 3.488

10.  Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.

Authors:  Jaya Prabhakaran; Victoria Arango; Vattoly J Majo; Norman R Simpson; Suham A Kassir; Mark D Underwood; Hanish Polavarapu; Jeffrey N Bruce; Peter Canoll; J John Mann; J S Dileep Kumar
Journal:  Bioorg Med Chem Lett       Date:  2012-06-07       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.